Skip to main content

Guillem Pons Barcons

Institutions of which they are part

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Guillem Pons Barcons

Institutions of which they are part

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Desarrollo avanzado de terapias innovadoras contra los sarcomas infantiles: refinamiento del bloqueo farmacológico de los co-receptores de la Vía Hedgehog

IP: Josep Roma Castanyer
Collaborators: Guillem Pons Barcons, Raquel Hladun Alvaro, Desarrollo avanzado de terapias innovadoras contra los sarcomas infantiles: refinamiento del bloqueo farmacológico de los co-re, Lia Garcia Gilabert, Gabriela Guillén Burrieza, Patricia Zarzosa Martinez
Funding agency: Instituto de Salud Carlos III
Funding: 190000
Reference: PI24/00825
Duration: 01/01/2025 - 31/12/2027

Development of a novel and potent strategy for blocking the Hedgehog pathway to treat pediatric sarcomas

IP: Josep Roma Castanyer
Collaborators: Guillem Pons Barcons, Raquel Hladun Alvaro, Development of a novel and potent strategy for blocking the Hedgehog pathway to treat pediatric sarcomas, Lia Garcia Gilabert, Patricia Zarzosa Martinez, Lucas Moreno Martín-Retortillo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2024 LLAV 00024
Duration: 02/12/2024 - 01/06/2025

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Gabriela Guillén Burrieza, Laura Alonso Garcia, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 30/06/2025

Desarrollo de nuevos fármacos basados en la inhibición de los co-receptores de la vía Hedgehog

IP: Josep Roma Castanyer
Collaborators: Soledad Gallego Melcón, Guillem Pons Barcons, Constantino Sábado Álvarez, Raquel Hladun Alvaro, Patricia Zarzosa Martinez
Funding agency: Instituto de Salud Carlos III
Funding: 122815
Reference: PI21/00640
Duration: 01/01/2022 - 31/12/2025

Related news

The study analyzes the impact of COVID-19 on people with rare red blood cell disorders, identifying risk factors for severe forms of the disease.

The association, once again, has shown its commitment to oncological research with a donation of €19,197 to the Cancer and Hematological Diseases Group for Children at VHIR.

The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up.

Related professionals

Maria Alvarez de Toledo López

Maria Alvarez de Toledo López

Predoctoral researcher
Infection and immunity in pediatric patients
Read more
Xavier Cañas Perea

Xavier Cañas Perea

Director/a d'Àrea
Clinical Research Development Directorate
Read more
Olga Galera Román

Olga Galera Román

Predoctoral researcher
Infectious Diseases
Read more
Angelica Maria Salas Perdomo

Angelica Maria Salas Perdomo

Tècnic/a Grau Superior
Lab Animal Service (LAS)
Preclinical Core Facilities
External Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.